0 Evaluaciones
ID

12244

Descripción

An open-label, multicenter, randomized, comparative, phase III study to evaluate the efficacy and safety of rituximab plus fludarabine and cyclophosphamide (FCR) versus fludarabine and cyclophosphamide alone (FC) in previously treated patients with CD20 positive B-cell chronic lymphocytic leukemia (CLL). FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients NCT00090051 Roche BO17072

Palabras clave

Versiones (3)
  1. 1/10/15 1/10/15 -
  2. 28/10/15 28/10/15 -
  3. 28/10/15 28/10/15 -
Subido en

28 de octubre de 2015

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0 Legacy
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    CLL Pharmacokinetics BO17072 NCT00090051

    Inglés

    Pharmacokinetics Cycle 1 and 3 of Chronic lymphocytic leukemia NCT0090051

    1 formularios  
    Blood sampling for pharmacokinetics (Rituximab)
    Descripción

    Blood sampling for pharmacokinetics (Rituximab)

    Scheduled sampling time
    Descripción

    Scheduled sampling time

    Tipo de datos

    time

    Unidades de medida
    • h
    Alias
    UMLS CUI [1]
    C0040223
    h
    Scheduled sampling date
    Descripción

    Scheduled sampling date

    Tipo de datos

    date

    Alias
    UMLS CUI [1]
    C0011008
    Sample number
    Descripción

    Sample number

    Tipo de datos

    integer

    Alias
    UMLS CUI [1]
    C1299222
    Sample collection date
    Descripción

    Sample collection date

    Tipo de datos

    date

    Unidades de medida
    • dd/mm/yy
    Alias
    UMLS CUI [1]
    C1549498
    dd/mm/yy
    Sample collection time
    Descripción

    Sample collection time

    Tipo de datos

    time

    Unidades de medida
    • hh:mm
    Alias
    UMLS CUI [1]
    C0427352
    hh:mm
    Remarks
    Descripción

    Remarks

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C0947611
    If patient takes Rituximab on day 1, then start of Fludarabine and Cyclophosphamide pharmacokinetic sampling starts on day 2, immediately prior the infusion.
    Descripción

    If patient takes Rituximab on day 1, then start of Fludarabine and Cyclophosphamide pharmacokinetic sampling starts on day 2, immediately prior the infusion.

    Scheduled sampling time
    Descripción

    After the end of infusion

    Tipo de datos

    time

    Unidades de medida
    • h
    Alias
    UMLS CUI [1]
    C0040223
    h
    Sampling number
    Descripción

    Sampling number

    Tipo de datos

    integer

    Alias
    UMLS CUI [1]
    C1299222
    Sample collection date
    Descripción

    Sample collection date

    Tipo de datos

    date

    Unidades de medida
    • dd/mm/yy
    Alias
    UMLS CUI [1]
    C1549498
    dd/mm/yy
    Sample collection time
    Descripción

    Sample collection time

    Tipo de datos

    time

    Unidades de medida
    • hh:mm
    Alias
    UMLS CUI [1]
    C0427352
    hh:mm
    Remarks
    Descripción

    Remarks

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C0947611
    Volver a la parte superior de la página

    Similar models

    Pharmacokinetics Cycle 1 and 3 of Chronic lymphocytic leukemia NCT0090051

    1 formularios
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    Blood sampling for pharmacokinetics (Rituximab)
    Scheduled sampling time
    Item
    Scheduled sampling time
    time
    C0040223 (UMLS CUI [1])
    Scheduled sampling date
    Item
    Scheduled sampling date
    date
    C0011008 (UMLS CUI [1])
    Sample number
    Item
    Sample number
    integer
    C1299222 (UMLS CUI [1])
    Sample collection date
    Item
    Sample collection date
    date
    C1549498 (UMLS CUI [1])
    Sample collection time
    Item
    Sample collection time
    time
    C0427352 (UMLS CUI [1])
    Remarks
    Item
    Remarks
    text
    C0947611 (UMLS CUI [1])
    Item Group
    If patient takes Rituximab on day 1, then start of Fludarabine and Cyclophosphamide pharmacokinetic sampling starts on day 2, immediately prior the infusion.
    Scheduled sampling time
    Item
    Scheduled sampling time
    time
    C0040223 (UMLS CUI [1])
    Sampling number
    Item
    Sampling number
    integer
    C1299222 (UMLS CUI [1])
    Sample collection date
    Item
    Sample collection date
    date
    C1549498 (UMLS CUI [1])
    Sample collection time
    Item
    Sample collection time
    time
    C0427352 (UMLS CUI [1])
    Remarks
    Item
    Remarks
    text
    C0947611 (UMLS CUI [1])
    Volver a la parte superior de la página 

    Ayuda

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial